References
- Carretero OA, Oparil S Essential hypertension. Part I: definition and etiology. Circulation, 2000; 101:329–335. doi: 10.1161/01.cir.101.3.329
- Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension. Role of angiotensinogen. Cell 1992;71:169–80.
- Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X. Sevenlessons from two candidate genes in human essential hypertension: angiotensinogenand epithelial sodium channel. Hypertension 1999;33:1324–31.
- Li NF, Zhou L,Wu WD, et al. The relationship between the variants in 50 upstream core promoter A (-6) G and A (-20) C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004;21:23–8.
- Pereira AC, Mota GFA, Cunha RS, et al. Angiotensinogen 235T allele “dosage” is associated with blood pressure phenotypes. Hypertension 2003;41:25–30.
- Van den Born BJ, Van Montfrans GA, Uitterlinden, AG, et al. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens 2007;25:2227–33.
- Jeunemaitre X, Inoue I, Williams C, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60:1448–60.
- Rodrı´guez-Pe´rez JC, Rodrı´guez-Esparrago´n F, Herna´ndez-Perera O, et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the procagene study. J Am Coll Cardiol 2001;37:1536–42.
- Pereira TV, Nunes ACF, Rudnicki M, et al. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension. A role beyond M235T? Hypertension 2008; 51: 778–83.
- Fang YJ, Deng HB, Thomas GN, et al. Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of HongKong Chinese. J Hypertens 2010;28:1203–9.
- Ji LD, Zhang LN, Shen P, et al. Association of angiotensinogen gene M235T and angiotensin-converting enzyme gene I/D polymorphisms with essential hypertension in Han Chinese population: a meta-analysis. J Hypertens 2010;28:419–28.
- Vamsi MU, Swapna N, Reddy S, Padma T. Gender related association of AGT gene variants (M235T and T174M) with essential hypertension – a case control study. Clin Exp Hypertens 2012;34:38–44.
- Charita Bh, Padma G, Sushma P, et al. Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: a case control study. J Renin Angiotensin Aldosterone Syst 2012;13:461–71.
- Padma G, Bhupatiraju C, Srinivas B, Padma T. High risk for essential hypertension in males conferred by g.15241A4G polymorphism in intron 3 of AGT gene. Clin Exp Hypertens 2013;35:108–11.
- Padma G, Charita Bh, Swapna N, et al. Novel variants detected in AGT gene among patients with essential hypertension. J Renin Angiotensin Aldosterone Syst. 2015;16(3): 642–646..
- Kurtz TW. Genome-wide association studies will unlock the genetic basis of hypertension. con side of the argument. Hypertension 2010;56:1021–1025.
- Dominiczak AF, Munroe PB. Genome-wide association studies will unlock the genetic basis of hypertension: pro side of the argument. Hypertension 2010;56:1017–1020; discussion 1025.
- Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep 2010;12:17–25.
- International Consortium for Blood Pressure Genome-Wide Association S, Ehret GB, Munroe PB, Rice KM, Bochud M, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011;478:103–109.
- Padma G, Swapna N, Mamata M, Charita Bh, Padma T. Risk conferred by tagged SNPs of AGT gene in causing susceptibility to essential hypertension Clin Exp Hypertens 2014;36(8):579–585.
- Lahiri DK, Nurnberger Jr, JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
- Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002;34:88–95.
- Kunes J, Zicha J. The interaction of genetic and environmental factors in the etiology of hypertension Physiol Res 2009;58:33–S41.
- Desmet FO, Hamroun D, Lalande M, et al. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009;37:e67.
- Ishigami T, Umemura S, Tamura K, et al. Essential hypertension and 50 upstream core promoter region of human angiotensinogen gene. Hypertension 1997;30:1325–45.
- Rahmouni K, Correia MLG, Haynes WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45:9–14.
- Narkiewicz K. Obesity and hypertension – the issue is more complex than we thought. Nephrol Dial Transplant 2006;21:264–7.
- Lindan Ji, Xiaobo Cai, Lina Zhang, et al. Association between Polymorphisms in the ReninAngiotensin-Aldosterone System Genes and Essential Hypertension in the Han Chinese Population. Plos One 2013;8(8): e72701
- Kunes J, Zicha J. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist’s view. Clin Sci (Lond) 2006;111:295–305.
- Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138–47.